SCHEMBL1006181

SCHEMBL1006181

COC(=O)c1cc(Cl)cc2oc(=S)[nH]c12

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PSMB8 P28062 5/20 0.48
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
SERPINH1 P50454 1/20 0.41
ABL1 P00519 1/20 0.38
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NR4A2 P43354 2/20 0.37
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 2/20 0.35
XBP1 P17861 1/20 0.35
HTT P42858 1/20 0.35
PDK2 Q15119 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1005404 0.77 PSMB8 (0.56) PSMB8ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL1077462 0.69 MEN1 (0.57) MEN1KMT2ASERPINH1ABL1ALDH1A1
SCHEMBL5189548 0.69 MEN1 (0.47) MEN1KMT2ASERPINH1ABL1NR4A2
SCHEMBL1004828 0.69 PSMB8 (0.42) PSMB8KMT2AABL1ALDH1A1HPGD
SCHEMBL1005229 0.68 ALDH1A1 (0.40) MEN1KMT2ASERPINH1ABL1ALDH1A1
SCHEMBL2313934 0.67 CREBBP (0.47) MEN1KMT2ASERPINH1ABL1ALDH1A1
SCHEMBL20541577 0.66 CHEK1 (0.50) MEN1KMT2ASERPINH1ABL1NR4A2
SCHEMBL16197979 0.66 MEN1 (0.42) MEN1KMT2ASERPINH1ABL1ALDH1A1
SCHEMBL5189583 0.66 MEN1 (0.48) MEN1KMT2ASERPINH1ABL1ALDH1A1
SCHEMBL1006187 0.66 HTR3A (0.51) SERPINH1ABL1ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7863271-B2 2-aminobenzoxazole carboxamides as 5HT3 modulators ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
US-7863271-B2 2-aminobenzoxazole carboxamides as 5HT3 modulators ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
US-7863271-B2 2-aminobenzoxazole carboxamides as 5HT3 modulators ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-04 US disclosed
EP-2061460-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS Albany Molecular Research, Inc. (US) 2009-05-27 EP disclosed
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS AMR TECHNOLOGY, INC. (US) 2008-10-16 US disclosed
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS AMR TECHNOLOGY, INC. (US) 2008-10-16 US disclosed
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS AMR TECHNOLOGY, INC. (US) 2008-10-16 US disclosed
WO-2008019372-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS ALBANY MOLECULAR RESEARCH, INC. (US) 2008-02-14 WO disclosed
WO-2008019372-A2 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS ALBANY MOLECULAR RESEARCH, INC. (US) 2008-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255114-A1 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5HT3 MODULATORS HTR3E, HTR3C, HTR3A PSMB8 3493/4885MEN1 1199/4885KMT2A 2162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.